Clinical Trial Update: Effect of GSK962040 on Oesophageal Function [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating GSK962040 for effects on esophageal function has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Motility Disorders

Drugs mentioned

• GSK962040

Snippet

Sponsor: GlaxoSmithKline | Conditions: Gastrointestinal Motility | Phase 1 | Status: COMPLETED